G0-C14

Catalog No. :
ACBUFA051
CAS No. :
1510653-27-6
Molecular Formula :
C106H216N10O10
Molecular Weight :
1790.95

IUPAC Name:3,3'-(13,34-dihydroxy-15,32-bis(2-hydroxytetradecyl)-19,28-dioxo-15,18,22,25,29,32-hexaazahexatetracontane-22,25-diyl)bis(N-(2-((2-hydroxytetradecyl)amino)ethyl)propanamide)

G0-C14 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$192.00Login to see priceInquiryInquiry
5mg95%$423.00Login to see priceInquiryInquiry
10mg95%$677.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameG0-C14
IUPAC Name3,3'-(13,34-dihydroxy-15,32-bis(2-hydroxytetradecyl)-19,28-dioxo-15,18,22,25,29,32-hexaazahexatetracontane-22,25-diyl)bis(N-(2-((2-hydroxytetradecyl)amino)ethyl)propanamide)
MDL No.MFCD35066972
Molecular FormulaC106H216N10O10
Molecular Weight1790.95
SMILESO=C(NCCNCC(O)CCCCCCCCCCCC)CCN(CCC(NCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)=O)CCN(CCC(NCCNCC(O)CCCCCCCCCCCC)=O)CCC(NCCN(CC(O)CCCCCCCCCCCC)CC(O)CCCCCCCCCCCC)=O
InChI KeyTZVPPOIQUSWFOD-UHFFFAOYSA-N
Synonym4,7,11,14-Tetraazaoctacosanamide, N-[2-[bis(2-hydroxytetradecyl)amino]ethyl]-16-hydroxy-14-(2-hydroxytetradecyl)-4,7-bis[3-[[2-[(2-hydroxytetradecyl)amino]ethyl]amino]-3-oxopropyl]-10-oxo-;G0-C14
CAS No.1510653-27-6

Synthetic Route by SureRoute

1. ACBUFA051 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBUFA051 route product structure diagram
    ACBUFA0511510653-27-6
Inquiry

2. ACBUFA051 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBUFA051 route product structure diagram
    ACBUFA0511510653-27-6
Inquiry

Comments (0)